ASLAN Pharmaceuticals Limited ASLN
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 777.12M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.03
- Beta
- 1.40
- Short ratio
- 1.85
- Inst. own
- 13.21%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 9, 2024
- 50-d avg
- 1.07
- 200-d avg
- 3.48
- 1y target
- 72.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for ASLN has not been loaded yet. Try again in a moment.
Altman Z-Score
-14.91 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.4×
P/S 1.4×
P/B -1.3×
P/FCF -0.4×
EV/EBITDA -0.6×
EV/Sales 1.9×
FCF Yield -269.8%
Gross Margin 97.1%
Operating Margin -364.5%
Net Margin -368.5%
ROE 332.8%
ROIC -323.1%
ROA -179.6%
Revenue 0.0%
Operating Income 8.7%
EPS (diluted) 26.9%
Free Cash Flow -20.7%
Current Ratio 1.8×
Quick Ratio 1.8×
Debt / Equity -2.0×
Net Debt / EBITDA -0.1×
Interest Coverage -10.1×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2023-12-31